Application of chimeric antigen receptor-regulatory T cell immunotherapy in organ transplantation / 器官移植
Organ Transplantation
;
(6): 547-2020.
Artículo
en Chino
| WPRIM
| ID: wpr-825569
ABSTRACT
Regulatory T cell (Treg) is a subset of T cells that negatively regulates immunity and has the function of inhibiting rejection. The specific modification of Treg by chimeric antigen receptor (CAR) technology can successfully chime donor-specific antigen onto the surface of Treg, thus regulating the immune function of the body in a real-time manner. It provides a novel and promising therapeutic option for inducing immune tolerance. In this article, research progresses on Treg in immune related diseases, main difficulties in the realization of CAR-Treg technology and its role in inducing transplantation immune tolerance were reviewed, and the opportunities and challenges of CAR-Treg application in the field of organ transplantation are prospected.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Organ Transplantation
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS